8-K/A: Perrigo Reports Solid Q3 2024 Results Driven by Margin Expansion and Infant Formula Recovery

Perrigo's third quarter 2024 results show significant operating income growth and margin expansion, fueled by the recovery of its infant formula business and strategic initiatives.

Summary

• Perrigo reported a 3.2% decrease in net sales to $1.1 billion for the third quarter of 2024, with organic net sales down 2.4%.
• The decline was primarily due to lost distribution of lower margin products in the U.S. Store Brand, which was partially offset by growth in other areas.
• Consumer Self-Care International (CSCI) saw a 1.0% net sales decrease, but organic sales grew by 1.0%, driven by cough and cold products.
• Consumer Self-Care Americas (CSCA) net sales decreased by 4.6%, impacted by lost distribution, but infant formula sales grew by 3% year-over-year and 58% sequentially.
• GAAP gross margin increased by 60 basis points to 37.2%, while adjusted gross margin expanded by 160 basis points to 41.0%.
• GAAP operating income was $80 million, up from $62 million, and adjusted operating income increased by 21.3% to $182 million.
• Adjusted diluted EPS was $0.81, a 26.6% increase from $0.64 in the prior year quarter.
• The company reaffirmed its fiscal 2024 adjusted EPS outlook of $2.50 to $2.65.
• Project Energize, a three-year program, is expected to deliver $140 million to $170 million in annualized pre-tax savings by 2026, with $40 million to $60 million reinvested.
• Year-to-date, Project Energize has achieved gross savings of approximately $95 million, with $16 million reinvested.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong earnings growth, margin expansion, and progress in the infant formula business. However, the decrease in net sales and the lower end of the outlook temper the overall optimism.

Positives

• The company achieved significant growth in adjusted operating income and adjusted diluted EPS.
• The infant formula business is showing strong signs of recovery with substantial sales growth and market share gains.
• Gross and operating margins expanded due to the infant formula recovery, supply chain improvements, and favorable product mix.
• Project Energize is on track to deliver substantial cost savings and improve organizational agility.
• The company successfully refinanced debt, lowering its average interest rate without increasing total long-term debt.
• Perrigo is making progress on its 'One Perrigo' vision by stabilizing core businesses and investing in capabilities.

Negatives

• Net sales decreased by 3.2% in the third quarter of 2024.
• Organic net sales declined by 2.4% due to lost distribution of lower margin products.
• The company expects its fiscal 2024 organic net sales and reported net sales outlooks towards the lower end of its previously stated ranges.
• Reported diluted loss per share was $(0.13), compared to reported diluted earnings per share of $0.11 in the prior year quarter.
• Year-to-date net sales decreased by 7.5% compared to the prior year period.

Risks

• The company faces challenges from lost distribution of lower margin products in the U.S. Store Brand.
• There are ongoing risks related to supply chain disruptions and economic conditions.
• The company is exposed to fluctuations in currency exchange rates and interest rates.
• The company is still working to fully recover the infant formula business.
• There are risks associated with the integration of acquisitions and the achievement of expected synergies.
• The company is exposed to potential costs and reputational impact of product recalls or sales halts.

Future Outlook

The company expects its fiscal 2024 organic net sales and total net sales outlook to be towards the lower end of their previously stated ranges and reaffirms its adjusted diluted EPS outlook of $2.50 to $2.65. They also expect gross and operating margin expansion.

Management Comments

• Patrick Lockwood-Taylor, President and CEO, stated that the company made significant progress to advance their 'One Perrigo' vision.
• He noted strong third quarter earnings results despite topline impacts from lost distribution.
• He highlighted the significant progress in the infant formula business recovery.
• He mentioned the team remains focused on de-levering the balance sheet, free cash flow generation, and furthering the recovery of the infant formula business.

Industry Context

Perrigo's results reflect the challenges and opportunities in the consumer self-care industry, including competitive pressures, supply chain issues, and the importance of strategic initiatives to drive growth and profitability. The infant formula recovery is a key focus, aligning with broader market trends in the nutrition sector.

Comparison to Industry Standards

• Perrigo's adjusted gross margin of 41.0% is comparable to other major consumer healthcare companies such as Haleon (which reported an adjusted gross margin of 61.5% in their most recent results) and Reckitt (which reported an adjusted gross margin of 59.8% in their most recent results), though Perrigo's is lower.
• Perrigo's adjusted operating margin of 16.8% is lower than Haleon's 23.2% and Reckitt's 23.6%, indicating room for improvement in operational efficiency.
• The 26.6% increase in adjusted diluted EPS is a positive sign, but it is important to compare this to the growth rates of peers to assess relative performance.
• The infant formula recovery is a key differentiator for Perrigo, as other companies may not have the same level of exposure to this market segment.
• The Project Energize cost savings program is similar to initiatives undertaken by other companies to improve profitability and efficiency.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and EPS growth.
• Employees may experience changes due to the Project Energize restructuring program.
• Customers will benefit from the improved supply chain and product availability, particularly in infant formula.
• Suppliers may see changes in demand and procurement as the company optimizes its supply chain.
• Creditors will see improved financial stability due to debt refinancing and cash flow generation.

Next Steps

• The company will continue to execute Project Energize to achieve cost savings and improve organizational agility.
• Perrigo will focus on further recovery of the infant formula business.
• The company will continue to de-lever the balance sheet and generate free cash flow.
• Perrigo will work towards building a solid foundation for long-term sustainable growth.

Key Dates

Keywords

Perrigo, Consumer Self-Care, Infant Formula, Operating Income, Gross Margin, Adjusted EPS, Project Energize, Net Sales, Debt Refinancing, Organic Growth